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A series of pinane-type sulfides and sulfoxides were synthesized from (1S)-(–)--pinene. Their hemocoagu-
lation activity in vitro on human blood plasma was studied. All tested compounds exhibited antiaggregation
and anticoagulation activity. The most water-soluble sulfoxide with a mercaptoacetic acid moiety inhibited
spontaneous platelet aggregation and that induced by collagen and arachidonic acid and also reduced the coagu-
lation activity of human blood plasma. The hemocoagulation activity was due to selective inhibition of platelet
receptors, decreased yield of thrombocytic microvesicles, and suppression of their activity.
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Cardiovascular diseases, among which ischemic heart
disease (IHD) (51%) and ischemic infarct (27%) play lead-
ing roles, remain the main global cause of death. These dis-
eases result from atherosclerotic inflammation of the blood
vessels that damages the vessel wall and activates platelets
and coagulation hemostasis, which in turn causes clots to
form and blood flow to vitally important organs to stop.
These changes are induced by various physiological and
pathological agents that activate specific cellular receptors
that transform the cellular membrane and render its surface
thrombogenic. The search for new drugs capable of affecting
these processes and correcting them is a critical task for de-
signing anticlotting drugs. We hypothesized that sulfur(S)-
containing terpenoids may possess such properties.
We showed earlier that S-containing monoterpenoids
synthesized by us possessed high antifungal, anti-inflamma-
tory, and antihelicobacter activity in combination with low
toxicity [1 – 3].
Herein, pinane-type sulfides II and III and sulfoxides
IV – VI were investigated for the first time for possible ap-
plication to correct disruptions of an in vitro hemostasis sys-
tem. The sulfides were synthesized by electrophilic addition
of thiols to the double bond of (1S)-(–)--pinene (I) in the
presence of ZnCl
2
[4]. Sulfoxides IV and V were prepared
via oxidation of the corresponding sulfides using m-chloro-
perbenzoic acid [5 – 7]; sulfoxide VI, using peracetic acid.
The structures of the products isolated by column chro-
matography were established using spectral data.
EXPERIMENTALCHEMICAL PART
PMR spectra were measured in CDCl
3
with TMS inter-
nal standard on a Varian Unity spectrometer (300 MHz). Re-
action products were isolated and purified using adsorption
chromatography over silica gel L (100/160). The course of
reactions and separation efficiency of reaction mixtures were
monitored by TLC on Silufol plates (I
2
detection). The syn-
theses and spectral data of I – V were published before
[3, 4]. Solvents were purified and dried using known meth-
ods [8].
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